Entera Bio Ltd (ENTX)
2.425
-0.18
(-6.73%)
USD |
NASDAQ |
May 17, 16:00
2.49
+0.06
(+2.68%)
After-Hours: 20:00
Entera Bio Price to Book Value: 9.852 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 9.852 |
| May 16, 2024 | 10.50 |
| May 15, 2024 | 10.58 |
| May 14, 2024 | 10.13 |
| May 13, 2024 | 9.448 |
| May 10, 2024 | 9.932 |
| May 09, 2024 | 10.26 |
| May 08, 2024 | 9.892 |
| May 07, 2024 | 9.973 |
| May 06, 2024 | 9.650 |
| May 03, 2024 | 8.658 |
| May 02, 2024 | 8.378 |
| May 01, 2024 | 8.017 |
| April 30, 2024 | 7.856 |
| April 29, 2024 | 8.057 |
| April 26, 2024 | 7.937 |
| April 25, 2024 | 8.017 |
| April 24, 2024 | 8.297 |
| April 23, 2024 | 8.899 |
| April 22, 2024 | 8.217 |
| April 19, 2024 | 7.977 |
| April 18, 2024 | 8.979 |
| April 17, 2024 | 8.899 |
| April 16, 2024 | 9.179 |
| April 15, 2024 | 10.10 |
| Date | Value |
|---|---|
| April 12, 2024 | 11.94 |
| April 11, 2024 | 10.66 |
| April 10, 2024 | 8.939 |
| April 09, 2024 | 9.019 |
| April 08, 2024 | 7.816 |
| April 05, 2024 | 7.957 |
| April 04, 2024 | 7.616 |
| April 03, 2024 | 6.934 |
| April 02, 2024 | 7.456 |
| April 01, 2024 | 7.496 |
| March 28, 2024 | 5.705 |
| March 27, 2024 | 5.261 |
| March 26, 2024 | 5.295 |
| March 25, 2024 | 5.329 |
| March 22, 2024 | 5.398 |
| March 21, 2024 | 5.876 |
| March 20, 2024 | 5.193 |
| March 19, 2024 | 4.818 |
| March 18, 2024 | 4.680 |
| March 15, 2024 | 4.680 |
| March 14, 2024 | 4.680 |
| March 13, 2024 | 4.954 |
| March 12, 2024 | 4.919 |
| March 11, 2024 | 4.988 |
| March 08, 2024 | 4.749 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.006
Minimum
Nov 11 2022
20.30
Maximum
Jun 23 2021
4.389
Average
3.551
Median
Oct 19 2020
Price to Book Value Benchmarks
| BiomX Inc | 6.072 |
| Compugen Ltd | 2.882 |
| Pluri Inc | -- |
| BioLine Rx Ltd | 3.869 |
| Can Fite Biofarma Ltd | 1.902 |
Price to Book Value Related Metrics
| PS Ratio | 564.28 |
| Price | 2.425 |
| Earnings Yield | -11.48% |
| Market Cap | 87.32M |